|
|
Volumn 14, Issue 3, 2002, Pages 301-308
|
|
Ralitrexed (Tomudex®) or Nordic-FLv regimen in metastatic colorectal cancer: A randomized phase II study focusing on quality of life, patients' preferences and health economics
a
|
|
Author keywords
Colorectal cancer; Health economy; Nordic FLv; Quality of life; Raltitrexed
|
|
Indexed keywords
FLUOROURACIL;
FOLINIC ACID;
NORDIC FLV;
RALTITREXED;
ANTINEOPLASTIC AGENT;
ANTINEOPLASTIC ANTIMETABOLITE;
QUINAZOLINE DERIVATIVE;
THIOPHENE DERIVATIVE;
ADULT;
AGED;
ARTICLE;
CLINICAL ARTICLE;
CLINICAL TRIAL;
COLORECTAL CANCER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG RESPONSE;
FEMALE;
HEALTH ECONOMICS;
HUMAN;
MALE;
METASTASIS;
MULTICENTER STUDY;
PATIENT ATTITUDE;
PHASE 2 CLINICAL TRIAL;
QUALITY OF LIFE;
RANDOMIZED CONTROLLED TRIAL;
TOXICITY TESTING;
COLORECTAL TUMOR;
DRUG ADMINISTRATION;
ECONOMICS;
HEALTH CARE COST;
LENGTH OF STAY;
MIDDLE AGED;
MORTALITY;
NORWAY;
PATHOLOGY;
QUESTIONNAIRE;
SURVIVAL;
TREATMENT OUTCOME;
AGED;
ANTIMETABOLITES, ANTINEOPLASTIC;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
COLORECTAL NEOPLASMS;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
FLUOROURACIL;
HEALTH CARE COSTS;
HUMANS;
LENGTH OF STAY;
LEUCOVORIN;
MALE;
MIDDLE AGED;
NEOPLASM METASTASIS;
NORWAY;
QUALITY OF LIFE;
QUESTIONNAIRES;
QUINAZOLINES;
SURVIVAL ANALYSIS;
THIOPHENES;
TREATMENT OUTCOME;
|
|
EID: 0035987009
PISSN: 1120009X
EISSN: None
Source Type: Journal
DOI: 10.1179/joc.2002.14.3.301 Document Type: Article |
|
Times cited : (10)
|
|
References (19)
|
